CNS Pharmaceuticals, Inc. (CNSP)
$5.35+0.00%Close
SELLRECOVERY · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 1.02
- P/E (TTM)
- -0.22
- Short % float
- 0.14%
- Days to cover
- 1.0
- SI change
- -69.8%
- 1W
- +0.56%
- 1M
- -6.96%
- vs SPY 1W
- -0.60%
- vs SPY 1M
- -9.95%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CNSP?
- LOPJLB’s latest quantitative signal on CNS Pharmaceuticals, Inc. (CNSP) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is CNSP in?
- CNS Pharmaceuticals, Inc. (CNSP) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does CNS Pharmaceuticals, Inc. (CNSP) do?
- CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of …